Brand Engagement Network (BNAI) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
20 Aug, 2026Executive summary
Completed the acquisition of Cataneo, a Germany-based media advertising technology company, expanding technology, customer base, and global presence.
Launched INTERVENT Health AI, a 50/50 joint venture to scale evidence-based health coaching with AI, and expanded partnerships in Africa and Latin America.
Made a $1 million strategic investment in Accelevate Solutions, targeting the fleet management and mobility sector, and expanded interests in Skye Africa Intelligence.
Reduced legacy liabilities and streamlined capital structure, including debt repayments and equity conversions.
Added to the Russell 3000 and Russell 2000 Indexes, increasing institutional investor visibility.
Financial highlights
Total assets increased to $30.7 million as of June 30, 2026, up from $15 million at year-end 2025, mainly due to Cataneo acquisition.
Shareholders' equity rose to $19.4 million from $3.5 million at year-end.
Cash and cash equivalents increased to $708,000 from $172,000 at year-end.
Accounts payable, short-term debt, and warrant liabilities reduced by approximately $3.3 million.
Revenue for the six months ended June 30, 2026 was $264,394, up from $15,000 year-over-year, driven by increased commercial traction and related party revenue.
Outlook and guidance
Cataneo integration expected to deliver cost synergies and meaningfully increase revenue base by year-end.
Focused on converting pilots and evaluations into recurring commercial revenue.
Management expects continued operating losses and negative cash flows for at least the next 12 months; additional capital will be required.
No specific timeline for revenue recognition from joint ventures; depends on commercial traction.
Realization of anticipated benefits is subject to integration risks.
Latest events from Brand Engagement Network
- Net loss narrowed and liabilities reduced, but liquidity and funding risks persist.BNAI
Q1 2026 - Net loss narrowed to $8.6M on minimal revenue; going concern risks and capital needs persist.BNAI
Q4 2025 - Double-digit growth in key metrics and strong liquidity set the stage for 2026 expansion.BNAI
Q3 2025 - Key votes include director elections, auditor ratification, and a reverse stock split for NASDAQ compliance.BNAI
Proxy Filing - Q2 2025 saw first revenue, major cost cuts, and net income, but liquidity risks remain.BNAI
Q2 2025 - Q3 2024 featured revenue growth, a $19.5M Cataneo deal, and a $50M equity facility.BNAI
Q3 2024 - Safe, customizable AI platform secures funding and partnerships, targeting healthcare deployments.BNAI
H.C. Wainwright 26th Annual Global Investment Conference 2024 - Flat revenue, widened net loss, and new partnerships set stage for H2 AI deployment growth.BNAI
Q2 2024 - $13.475M write-off, $19.5M Cataneo deal, and new sector partnerships drive global AI growth.BNAI
Q4 2024